Presentaciones a congresos

In vitro activity of ceftazidime-avibactam against contemporary carbapenem-resistant/carbapenemase-producing Enterobacteriales and Pseudomonas aeruginosa clinical isolates from Argentina

Abr 13, 2019

Fernando Pasteran, Diego Danze, Alejandra Menocal, Maria Elena Dattero, Luciana Soken, Ezequiel Albornoz, Paola Ceriana, Alejandra Corso

ECCMID 2019 29th European Congress of Clinical Microbiology & Infectious Diseases, Amsterdam, Netherlands, 13 – 16 April 2019

In vitro activity of ceftazidime-avibactam against contemporary carbapenem-resistant/carbapenemase-producing Enterobacteriales and Pseudomonas aeruginosa clinical isolates from Argentina

Entrada relacionada

Carrusel Presentaciones a congresos Publicaciones

Evaluation of the ability of the Gene Xpert Carba-R system to detect KPC and IMP carbapenemases variants

May 7, 2024
Carrusel Presentaciones a congresos Publicaciones

Evaluation of an immunochromatographic method (NG-TEST® CARBA-5) for detection of different allelic variants of KPC, NDM, IMP and VIM carbapenemases in Enterobacterales (ETB) and Pseudomonas aeruginosa (PAE) isolates

May 7, 2024
Presentaciones a congresos Publicaciones

New insights in therapeutic options against difficult-to-threat Pseudomonas aeruginosa (DTR-PA): in vitro activity of aztreonam in combination with avibactam, relebactam and in double ?-lactams combinations with ceftazidime/avibactam and imipenem/relebactam.

May 7, 2024